USPTO 2015–2025 USPTO PatentsView US Corporation

Gilead Sciences, Inc.

USPTO PatentsView assignee record — 561 granted patents across 18 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

561
Total patents granted
18
CPC technology areas
19.1
Avg claims per patent
+13%
5-year filing velocity

Portfolio overview

Gilead Sciences, Inc. has been granted 561 US utility patents between 2015 and 2025, placing Gilead Sciences, Inc. at rank #817 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Gilead Sciences, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 57.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 298 grants, compared with 263 in the 2015–2019 window — a +13% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Gilead Sciences, Inc.'s 19.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Gilead Sciences, Inc. against peers pursuing similar technology classes.

How does Gilead compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Gilead holds 561 patents — placing it at rank #817 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

304050607080 20152016201720182019202020212022202320242025 39
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Gilead Sciences, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 54 9.6%
2016 52 9.3%
2017 56 10.0%
2018 46 8.2%
2019 55 9.8%
2020 37 6.6%
2021 41 7.3%
2022 42 7.5%
2023 65 11.6%
2024 74 13.2%
2025 39 7.0%

Which technologies does Gilead Sciences, Inc. patent most?

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#817

Across all tracked assignees

Innovation Score

57.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Gilead Sciences, Inc. hold?
Gilead Sciences, Inc. holds 561 US granted patents filed between 2015 and 2025, spanning 18 technology areas.
What is Gilead Sciences, Inc.'s Innovation Score?
Gilead Sciences, Inc. has an Innovation Score of 57.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Gilead Sciences, Inc. focus on?
Gilead Sciences, Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 492 patents. The company has filed patents in 18 CPC subclasses total.
Is Gilead Sciences, Inc.'s patent filing rate increasing or decreasing?
Gilead Sciences, Inc.'s recent filing velocity is +13% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Gilead Sciences, Inc.'s patents?
Gilead Sciences, Inc.'s patents average 19.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Gilead Sciences, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope